Behind hospitals stand the physicians caring for patients each day. Behind them? A lot of data on patients. And, behind all that information is Edison’s HealthEC, a company that might be multiple layers removed from the hospital setting — but its impact on those facilities’ ability to keep the lights on is hard to miss.
The third quarter will answer crucial questions about the near-term future of digital health. Will the upstart companies that enabled care and clinical trials to continue remotely during the pandemic have the same resonance and revenue growth as it recedes? Will they keep finding exit avenues via acquisitions, IPOs, or SPAC mergers?
According to a new survey of almost 100 mid-sized tech companies by Marsh & McLennan Insurance Agency, employers across the country are rolling out new employee benefits and perks and enhancing existing programs. Responding to the lessons from the pandemic and demand for more flexible work arrangements, companies are more focused on the mental, physical and financial health of their teams, as well as employee satisfaction. The pandemic has also elevated the importance of stress management solutions and work-life balance, and tech companies have wasted little time in offering creative solutions.
The Department of Health and Human Services doesn’t routinely share cyber threat information with private sector partners because the two centers responsible haven’t formalized coordination, according to the Government Accountability Office.
The world of work has changed massively in the last year, and with it a rush of startups have emerged with new technology and approaches to improve how it is shaped, and specifically how human resources departments do their jobs. In the latest chapter, Visier, a Canadian startup that has built a big-data engine to ingest and analyze information from disparate human resources and related applications to develop more accurate profiles of people and departments — useful when considering remuneration, promotions, and wider hiring budgets — has raised $125 million (USD), a Series E that the company confirms now values it at $1 billion.
Jeff Tangney launched his first health-tech start-up, Epocrates, in the middle of the dot-com bubble. While the company survived the crash and eventually went public, the endgame was a disappointing acquisition for less than $300 million. By the time Tangney started his next venture, Doximity, in 2010, he’d learned a few things: Don’t raise too much money. Don’t burn too much cash. Fix a real problem for doctors.